These data demonstrate that Pex11a deficiency impairs physical activity and energy expenditure, decreases fatty acid β‐oxidation, increases de novo lipogenesis and results in dyslipidaemia and obesity. Here, PEX11A is linked to obesity due to melanocortin 4 receptor deficiency.